Trends & Forecasts

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

AI, the Inflation Reduction Act, and a surge in precision medicine; experts look at pharma’s future.

Experts share their insights on the disruptive trends reshaping healthcare, including the rise of personalized medicine and digital innovation.

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.